Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00266773 · ClinicalTrials.gov registry record · NA
A Telephone Feedback System for Prevention of Chronic Pain Relapse
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT00266773: Completed NA study, sponsored by University of Vermont.
NCT00266773 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 158 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00266773, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a telephone-based self-monitoring and skills review program with personalized therapist feedback following group CST for chronic pain can reduce and prevent relapse of the pain, physical disability, and psychological distress experienced by patients with chronic pain of the muscles and bone.
Interventions
- BEHAVIORAL Chronic pain therapeutic interactive voice response (TIVR) system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2005-11 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT00266773 record still lists
NCT00266773 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Chronic pain therapeutic interactive voice response (TIVR) system is the first listed.
NCT00266773 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00266773 about?
NCT00266773 is a clinical study titled "A Telephone Feedback System for Prevention of Chronic Pain Relapse". The purpose of this study is to determine whether a telephone-based self-monitoring and skills review program with personalized therapist feedback following group CST for chronic pain can reduce and prevent relapse of the pain, physical disability, and psychological distress experienced by patients ...
What is the current status of trial NCT00266773?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2005-11. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00266773?
The interventions under investigation include: Chronic pain therapeutic interactive voice response (TIVR) system (BEHAVIORAL).
Who is sponsoring clinical trial NCT00266773?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00266773's enrollment target sits among peer trials
158 654th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia